rs387906712
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_013444.4(UBQLN2):c.1525C>T(p.Pro509Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000168 in 1,193,953 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 8 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_013444.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000445 AC: 5AN: 112235Hom.: 0 Cov.: 24 AF XY: 0.0000291 AC XY: 1AN XY: 34405
GnomAD3 exomes AF: 0.0000203 AC: 3AN: 148092Hom.: 0 AF XY: 0.0000217 AC XY: 1AN XY: 46024
GnomAD4 exome AF: 0.0000139 AC: 15AN: 1081718Hom.: 0 Cov.: 31 AF XY: 0.0000199 AC XY: 7AN XY: 351714
GnomAD4 genome AF: 0.0000445 AC: 5AN: 112235Hom.: 0 Cov.: 24 AF XY: 0.0000291 AC XY: 1AN XY: 34405
ClinVar
Submissions by phenotype
Amyotrophic lateral sclerosis type 15 Pathogenic:1Uncertain:1
- -
This sequence change replaces proline, which is neutral and non-polar, with serine, which is neutral and polar, at codon 509 of the UBQLN2 protein (p.Pro509Ser). This variant is present in population databases (rs387906712, gnomAD 0.005%), including at least one homozygous and/or hemizygous individual. This missense change has been observed in individual(s) with amyotrophic lateral sclerosis (PMID: 21857683). ClinVar contains an entry for this variant (Variation ID: 29953). Algorithms developed to predict the effect of variants on gene product structure and function are not available or were not evaluated for this variant. Experimental studies have shown that this missense change affects UBQLN2 function (PMID: 25616961, 26075709). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
UBQLN2-related disorder Uncertain:1
The UBQLN2 c.1525C>T variant is predicted to result in the amino acid substitution p.Pro509Ser. This variant was reported in an individual with amyotrophic lateral sclerosis (Deng et al. 2011. PubMed ID: 21857683) with functional in vitro studies suggesting this variant impairs protein function (Gilpin et al. 2015. PubMed ID: 25616961; Chang et al. 2015. PubMed ID: 26075709). This variant is reported in 0.0049% of alleles in individuals of European (Non-Finnish) descent in gnomAD. Although we suspect that this variant may be pathogenic, at this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at